Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment

Simple Summary Hyperthermia (HT) is a promising therapeutic option for multiple cancer entities as it has the potential to increase the cytotoxicity of radiotherapy (RT) and chemotherapy (CT). Thermometric parameters of HT are considered to have potential as predictive factors of treatment response. So far, only limited data about the prognostic and predictive role of thermometric parameters are available. In this review, we investigate the existing clinical evidence regarding the correlation of thermometric parameters and cancer response in clinical studies in which patients were treated with HT in combination with RT and/or CT. Some studies show that thermometric parameters correlate with treatment response, indicating their potential significance for treatment guidance. Thus, the establishment of specific thermometric parameters might pave the way towards a better standardization of HT treatment protocols. Hyperthermia (HT) is a cancer treatment modality which targets malignant tissues by heating to 40-43 degrees C. In addition to its direct antitumor effects, HT potently sensitizes the tumor to radiotherapy (RT) and chemotherapy (CT), thereby enabling complete eradication of some tumor entities as shown in randomized clinical trials. Despite the proven efficacy of HT in combination with classic cancer treatments, there are limited international standards for the delivery of HT in the clinical setting. Consequently, there is a large variability in reported data on thermometric parameters, including the temperature obtained from multiple reference points, heating duration, thermal dose, time interval, and sequence between HT and other treatment modalities. Evidence from some clinical trials indicates that thermal dose, which correlates with heating time and temperature achieved, could be used as a predictive marker for treatment efficacy in future studies. Similarly, other thermometric parameters when chosen optimally are associated with increased antitumor efficacy. This review summarizes the existing clinical evidence for the prognostic and predictive role of the most important thermometric parameters to guide the combined treatment of RT and CT with HT. In conclusion, we call for the standardization of thermometric parameters and stress the importance for their validation in future prospective clinical studies.